AINV is a common dose limiting toxicity that can impact adherence and quality of life. Pharmacists are in an ideal position to optimize management.
Learning Objectives:
- Describe the pathophysiology of AINV
- Apply recommendations from practice guidelines to the treatment of patients with AINV
- Recognize challenges with completing AINV assessment using patient examples
- Explain the importance of the multidisciplinary approach to AINV management
